6-氯-4-哌嗪基喹唑啉缩氨基硫脲类化合物的合成及体外抗肿瘤活性

以5-氯-2-氨基苯甲酸和甲酰胺为起始原料,经环化、氯化、取代和缩合反应,合成了3个未见文献报道的含哌嗪的喹唑啉衍生物5a~5c。 其结构用1H NMR、13C NMR、ESI-MS及IR测试技术进行了表征。 采用MTT法测试了化合物5a~5c对人胃癌SGC-7901、人口腔表皮样癌KB和人纤维肉瘤HT-1080的体外抗肿瘤活性。 结果表明,化合物5a~5c对人胃癌SGC-7901和人纤维肉瘤HT-1080有弱的抑制活性,而对人口腔表皮样癌KB无明显抑制活性。     

新型6-烷氧基大黄酸-氨基酸加合物的合成及抗肿瘤活性

以大黄素为起始原料，经乙酰化、氧化、去乙酰化、酯化、醚化、水解和缩合反应，合成了11个结构新颖的6 烷氧基取代的大黄酸 氨基酸加合物（8aa~8ee），其结构经¹H NMR, ¹³C NMR和HR MS(ESI-TOF)表征。采用四甲基偶氮唑盐法（MTT法）考察了目标化合物对子宫颈癌细胞（Hela）、人乳腺癌细胞（MCF-7）、人胚肾细胞（HEK-293T）和人胃癌细胞（SGC-7901）的体外抑制活性。结果表明：8ea对4株肿瘤细胞均有一定的抑制活性，并体现出较好的选择性。其中对SGC-7901的抑制活性（IC₅₀=9.78 μmol·L^-1）与阳性对照物顺铂和阿霉素相当。     

新型7-(2-羟亚胺-2-苯基)-乙氧基白杨素的合成及活性研究

以天然产物白杨素为原料,与多种α-溴代苯乙酮反应制得6种7-(2-羰基-2-苯基)乙氧基白杨素衍生物(2a~2f); 2a~2f与盐酸羟胺进行肟化反应,合成了6种新型的Z-构型7-(2-羟亚胺-2-苯基)乙氧基白杨素衍生物（3a～3f）,其结构经¹H NMR, ¹³C NMR, IR和HR-MS(ESI)表征。采用MTT法测试了3a~3f对人宫颈癌细胞株Hela和人胃癌细胞SGC-7901的体外抑制活性。结果表明：化合物3b和3e对Hela的抑制作用较好,IC₅₀分别为18.2和17.4 μmol·L-1。     

嘧啶拼接3-烯键氧化吲哚衍生物的合成及其抗肿瘤活性

以2-吲哚酮与3,5-二氯嘧啶甲醛为原料,经Knoevenagel加成消除反应和取代反应合成了11个新型的嘧啶拼接3-烯键氧化吲哚衍生物(3a~3k),产率70%~91%,Z/E值15：1~>20 ：1, 其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。采用MTT法研究了3a~3k对人肺癌细胞(A549)和人白血病细胞(K562)的体外抗肿瘤活性。结果表明：3a, 3c, 3f, 3g和3j对K562具有较好的抑制活性（IC₅₀分别为29.3, 27.6, 28.5, 24.0和27.0 μmol·L^-1）, 3a, 3h和3j对A549具有较好的抑制活性（IC₅₀分别为28.1, 16.4和25.2 μmol·L^-1）。     

N9位芳基取代嘌呤-8-酮类衍生物的合成及抗肿瘤活性

合成了一系列N9位芳基取代嘌呤-8-酮类衍生物, 利用核磁共振氢谱(¹H NMR)、 核磁共振碳谱(¹³C NMR)和高分辨质谱(HRMS)进行了结构确证. 采用四甲基偶氮唑盐(MTT)法测定了目标化合物的体外抗肿瘤细胞增殖活性. 结果表明, 嘌呤酮环的C2位及N9位的取代对活性有较大影响, C2位引入对位由含氮六元环取代的苯胺, N9位引入对三氟甲基苯均有利于提高抗肿瘤活性. 化合物12c对人白血病细胞(K562)、 人前列腺癌细胞(PC-3)、 人乳腺癌细胞(MDA-MB-231)及人结肠癌细胞(HCT116)的抑制效果明显优于阳性对照药R-Roscovitine.     

新型吲唑类化合物的合成及其抗肿瘤活性

以2,6-二氟苯腈与吗啉反应制得2-氟-6-吗啉-苯腈(1); 1与水合肼在N-甲基吡咯烷酮中通过环合反应制得3-氨基-4-吗啉-1H-吲唑(2); 2与不同羧酸经缩合反应合成了8个新型吲唑类化合物(4a~4h),其结构经¹H NMR, IR和HR-ESI-MS表征。抗肿瘤活性测试结果表明：3,4,5-三甲氧基-氮-(4-吗啉-1H-吲唑-3-基)苯甲酰胺（4a）的抗肿瘤活性最好,对K-562, SMMC7721和T-47D肿瘤细胞有明显抑制作用,IC₅₀分别为0.056 μmol·L^-1, 0.062 μmol·L^-1和0.078 μmol·L^-1。     

基于姜黄酮骨架的新型螺环氧化吲哚类化合物的合成及其抗癌活性

以取代靛红、芳姜二烯酮与α-氨基苯乙酸为原料,在甲苯中回流,经1,3-偶极子3+2环加成反应合成了3个新型的基于姜黄酮骨架螺环氧化吲哚类化合物(3a~3c),收率65%~73%, dr值10/1~15/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征,相对构型经3c的单晶结构确定。采用MTT法研究了3a~3c对人白血病细胞(K562)、人肺癌细胞(A549)和人前列腺癌(PC-3)的体外抗肿瘤活性。结果表明：化合物3b对K562具有明显的抑制活性（IC₅₀为37.5 μM）,接近于阳性对照药顺铂。     

新型六氢吡啶-2,3-并吲哚化合物的合成及其抗肿瘤活性

以3-取代氧化吲哚与丙烯酸酯为原料,经Michael加成反应制得中间体--3-丙酸酯取代氧化吲哚（3a~3d）; 3a~3d与甲胺发生酰胺化反应制得3 丙酰胺取代氧化吲哚（4a~4d）; 4a~4d用氢化铝锂还原-环化,合成了4个六氢吡啶-2,3-并吲哚化合物(5a~5d）; 5a和5b用氢化铝锂还原合成了2个六氢吡啶-2,3-并吲哚化合物（6a和6b）, 5a～5d, 6a和6b均为新化合物,总产率42%～61%,其结构经¹H NMR, ¹³C NMR和HR-ESI-MS表征。采用MTT法研究了5a～5d, 6a和6b对人肺癌细胞（A549）,人前列腺（PC-3）和人白血病细胞（K562）的体外抗肿瘤活性。结果表明：5b对A549, PC 3和K562的抑制活性均较好,其IC₅₀分别为27.2μmol·L^-1, 37.5 μmol·L^-1和21.7 μmol·L^-1。     

鱼藤素断环结构氨基酸衍生物的合成及其抗肿瘤活性

采用化学法,以异戊烯醛和2,4-二羟基苯甲醛为起始原料,经烯醛加成和醛胺缩合反应合成了4种新的鱼藤素断环结构氨基酸衍生物（3a~3d）,其结构经¹H NMR, ¹³C NMR和LC-MS表征。采用CCK8法将3a~3d作用于H1299肺癌细胞和HBE正常细胞,对其抗肿瘤活性和毒性进行初步研究。结果表明：3a~3d对肺癌H1299细胞增殖表现出不同程度的抑制作用,均呈现时间浓度依赖性。与鱼藤素相比,3a~3d的抗肿瘤活性下降,3d的活性最好,IC₅₀为655.8±34.7μmol·L^-1,但对HBE正常肺细胞的毒性明显小于鱼藤素。     

新型螺环吡咯酮双氧化吲哚类化合物的无催化剂合成及其抗白血病活性

以3-异硫氰基氧化吲哚与3-丙二腈缩合的3-烯氧化吲哚为原料,乙腈为溶剂,在无催化剂存在的条件下于室温发生[3+2]环加成反应,合成了6个新型的螺环吡咯酮双氧化吲哚类化合物(3a~3f),产率91%~95%,dr 17/1~>20/1,其结构经¹H NMR, ¹³C NMR和HR-MS（ESI-TOF）表征。采用MTT法研究了3a~3f对人白血病细胞(K562)的体外抗肿瘤活性。结果表明：化合物3c对K562具有明显的抑制活性（IC₅₀为36.3 μM）,与阳性对照药顺铂接近。     

吡啶-2,6-二甲酰腙类化合物及其Tb(Ⅲ)和Eu(Ⅲ)配合物的合成与荧光性能

吡啶-2,6-二甲酸经酯化,肼解得吡啶-2,6-二甲酰肼(2),(2)与芳香醛缩合得到了3个新的酰腙配体:吡啶-2,6-二甲酰肼苯甲醛腙(3a)、吡啶-2,6-二甲酰肼水杨醛腙(3b)和吡啶-2,6-二甲酰肼呋喃甲醛腙(3c),其结构经元素分析、IR、1HNMR和MS进行了确认。制备了吡啶-2,6-二甲酰肼与这三种新型配体的Tb(III)和Eu(III)配合物,并对配合物的溶液态的荧光性质进行了研究。结果表明,吡啶-2,6-二甲酰肼苯甲醛腙(3a)和吡啶-2,6-二甲酰水杨醛腙(3b)作为荧光敏化剂,对Eu3+和Tb3+的荧光敏化性能比吡啶-2,6-二甲酰肼以及大多数吡啶-2,6-二甲酸衍生物要好,是较理想的稀土荧光敏化剂,它们的稀土配合物在分子偶极矩较小的溶剂中荧光强度较强。     

七配位二聚体配合物{(PhCH2)2Sn·[2,6-(O2C)2C5H3N](CH3OH)}2的合成及结构

在三乙胺存在下利用三苄基氯化锡和2,6-吡啶二甲酸,以1:1摩尔比反应,合成了七配位二聚体{(PhCH2)2Sn[2,6-(O2C)2C5H3N](CH3OH)}2.通过元素分析、红外光谱和核磁共振氢谱对其结构进行了表征.用X射线单晶衍射法测定了该化合物的晶体结构.化合物为三斜晶系,P1空间群,晶胞参数a=0.9625(6)nm,b=1.0947(9)nm,c=1.996(3)nm,α=90.00(2)°,β=87.69(3)°,γ=90.00(3)°,Z=2,V=2.102(6)nm3,μ=1.248mm-1,F(000)=1000,R1=0.0476,wR2=0.0782.化合物中2个锡原子呈七配位畸变五角双锥构型.生物活性测试结果表明,该化合物具有较强的体外抗肿瘤活性.     

Synthesis and Crystal Structure of a Palladium(II) Coordination Polymer [Na_2Pd(2,6-pydc)_2(H_2O)_6]_n

A novel coordination polymer [Na2Pd(2,6-pydc)2(H2O)6]n (2,6-H2pydc = 2,6-pyri- dinedicarboxylic acid) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group P21/c, with a = 11.962(2), b = 6.5552(13), c = 12.673(3) , β = 91.72(3)°, V = 993.3(3) 3, Z = 2, Mr = 590.68, Dc = 1.975 g/cm3, μ = 1.059 mm-1, F(000) = 592, the final R = 0.0211 and wR = 0.0454. In the crystal the Pd(II) ion adopts a distorted four-coordinated square-planar geometry and bonds to two bidentate 2,6-pyridinedicarboxylate molecules through caronyl oxygen and pyridine nitrogen atoms. The title complex exhibits a novel three-dimensional network structure.     

Synthesis and Crystal Structure of a Palladium(Ⅱ)Coordination Polymer [Na2Pd(2,6-pydc)2(H2O)6]n

A novel coordination polymer [Na2Pd(2,6-pydc)2(H2O)6]n (2,6-H2pyde = 2,6-pyri-dinedicarboxylie acid) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinie system, space group P21/c,with a = 11.962(2), b = 6.5552(13), c = 12.673(3) A, β = 91.72(3)°, V= 993.3(3) A3,Z = 2, Mr=590.68, Dc = 1.975 g/cm3,μ=1.059 mm-1, F(000) = 592, the final R = 0.0211 and wR = 0.0454. In the crystal the Pd(Ⅱ) ion adopts a distorted four-coordinated square-planar geometry and bonds to two bidentate 2,6-pyridinedicarboxylate molecules through caronyl oxygen and pyridine nitrogen atoms. The title complex exhibits a novel three-dimensional network structure.     

Synthesis and Crystal Structure of（2E,6E）-2,6-bis（2,3-dimethoxybenzylidene）cyclohexanone

The new title compound (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene)cyclohexanone (C 24 H 26 O 5,M r=394.45) has been synthesized,and its crystal structure was studied.The title compound crystallizes in the orthorhombic system,space group Pca2 1 with a=17.536(2),b=14.8515(16),c=8.0512(9),V=2096.8(4) 3,Z=4,D c=1.250 g/cm 3,λ=0.71073,μ=0.087 mm-1 and F(000)=840.The structure was solved by direct methods and refined to R=0.0533 and wR=0.1248 from 2727 observed reflections (I > 2σ(Ⅰ)).The title molecules are connected through hydrogen bonds to generate a 3-D supramolecule.The preliminary biological tests showed definitely biological activity for the title compound.     

A New Diiminopyridyl Cobalt Complex [CoCl_2L]（L=2,6-Bis（N,N＇-bis（2,6-diisopropyl-4-（2,3-dimethyoxylbenzoylamide）phenylimino））pyridine）

The reaction of CoCl2·6H2O with 2,6-bis(N,N'-bis(2,6-diisopropyl-4-(2,3-dimethy-oxyl-benzoylamide)phenylimino))pyridine(L) afforded the complex [CoCl2L],which was fully characterized by elemental analysis,UV-vis,IR spectroscopy,fluorescence,and X-ray diffraction analysis.The compound is of triclinic system,space group P1 with a = 13.058(3),b = 13.798(3),c = 16.695(3) ,α = 98.191(3),β = 102.792(3),γ = 101.820(3)°,V = 2815.0(9) 3,Z = 2,F(000) = 1122,μ = 0.45 mm-1,R = 0.061 and wR = 0.1349 for 9842 observed reflections(Ⅰ 2σ(Ⅰ)).The Co(Ⅱ) center adopts a distorted square-pyramidal coordination geometry.The extended structure shows a one-dimensional zigzag double chain linked by hydrogen bonds and π-π stacking interactions.     

Synthesis and Crystal Structure of a Novel 3D Inorganic-organic Hybrid Metallic Coordination Polymer, [Na2Cd（2,6-pyda）（N3）2（H2O）6]n

A novel coordination polymer [Na2Cd（2,6-pyda）（N3）2（H2O）6]n （2,6-H2pyda = 2,6- pyridinedicarboxylic acid） has been synthesized and characterized by elemental analysis, IR and single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group C2/c, with a = 24.416（4）, b = 10.7638（17）, c = 6.9224（11） A^°, β= 106.124（2）A^°, V = 1747.7（5） A^°3, Mr = 515.64, De= 1.960 g/cm^3,μ = 1.365 mm^-1, F（000） = 1024, Z = 4, the final R = 0.0426 and wR = 0.1320. In the title complex, there exist two kinds of metal centers in the structure, cadmium ions and sodium ions. The Cd（Ⅱ） atom shows a distorted pentagonal-dipyramidal geometry defined by two O and one N atoms from one deprotonated pyda ligand and four N atoms from four μ-1,1,3 azido groups. The adjacent cadmium atoms are bridged via two μ-1,1,3 azido groups, along the c axis to afford an extended chain. There is also a 2D network which is comprised of binuclear subunits [NaE（H2O）6] connected by O atoms from coordinated water between the adjacent Cdn（pyda）n（Na）2n infinite chains. Furthermore, each cadmium atom is connected with four adjacent sodium atoms through the bridging N3- ligand in μ-1,3 patterns. Thus, the title complex exhibits a novel three-dimensional network structure.     

Synthesis and Crystal Structure of a Novel Zinc Complex[Zn(OH2)(HDPA)2]·3H2O

A new complex [Zn(OH2)(HDPA)2]·3H2O 1 (H2DPA = 2,6-pyridine-dicarboxylic acid) has been prepared at room temperature from the reaction of zinc(II) chloride and 2,6-pyri- dine-dicarboxylic acid in mixed solvent of H2O and EtOH with pyridine, and characterized by X-ray analysis and thermal analysis, exhibiting that the coordination geometry of Zn(II) ion is an octa- hedron. Crystal data: ZnC14H16N2O12, Mr = 469.66, monoclinic, P21/n, a = 7.0067(3), b = 23.8215 (12), c = 10.7404(3)(A), β = 99.823(2)°,V = 1766.40(13)(A)3, Z = 4, Dc = 1.766 g/cm3, F(000) = 960, μ = 1.463 mm-1, R1 = 0.0462 and wR2 = 0.0884 (I > 2σ(I)).     

Synthesis and Crystal Structure of a Novel Zinc Complex [Zn(OH_2)(HDPA)_2]·3H_2O

1INTRODUCTION In recent years,dicarboxylic acids have been wide-ly used as poly-dentate ligands involved in various metal chelation reactions to form transition or rare earth metal complexes with interesting properties in material science[1~3]and biological systems[4~7].For example,Kim,Y.and his coworkers focus on the syn-theses of copper(II)complexes containing ligands of malonate and pyrazine to study their electronic con-ductivity and magnetic property[8].The importance of Tr(II)/dic…     

钴与吡啶-2,6-二甲酸和邻菲咯啉三元配合物的合成与晶体结构

合成了钴(Ⅱ)与吡啶-2,6-二甲酸和邻菲咯啉三元配合物Co(DPC)(phen)(H_2O)]·2H_2O(DPC=C7H3O4N;phen=C12H8N2·H_2O),并获得其单晶。晶体学数据如下：C19H17CoN3O7, Mr = 458.29,三斜晶系, P空间群。 a = 7.818(1), b = 9.290(2), c = 14.048(3) ?, α = 81.477(1), β = 81.456(8), γ = 72.970(2)°, V = 958.7(3) ?3, Z =2, F(000) = 470, Dc= 1.588Mg/m3, μ(MoKα) = 0.944mm-1。中心Co(Ⅱ)离子为6配位,6个配位原子形成一个畸变的八面体构型。